CEDEA/ICGT and INSERM/Univ. Paris-Saclay - France

Author Profile

Early academic pursuits 🎓

Jerzy trojan completed his doctorate d’état ès sciences (hdr) at the prestigious sorbonne - p&m curie. during this formative period, he laid the groundwork for his future contributions to biomedical science, specifically in the field of cancerology. his early research endeavors, characterized by a rigorous scientific approach, focused on critical aspects of oncology and laid the foundation for his later groundbreaking work.

Professional endeavors 🏥

Jerzy has held various esteemed positions throughout his career, reflecting his commitment to advancing cancer research. he is currently a visiting professor at the insitm, cancer center, and paris-saclay university in villejuif, france, where he has been since 2019. before this, he served as president and research director at the international cancer gene therapy and oncology diagnostics center (ceadea) in bogota, colombia, and has also held prominent roles in institutions across the usa and europe, including case western reserve university and the sidney kimmel cancer center. these diverse experiences have equipped him with a comprehensive understanding of both the scientific and clinical aspects of cancer treatment.

Contributions and research focus 🔬

Dr. trojan is best known for establishing cancer gene therapy, particularly immuno-gene therapy, as a pivotal domain within oncology. his pioneering research, highlighted in publications from 1993, led to significant advancements in the treatment of glioblastoma, showcasing the therapeutic potential of gene therapy. Immuno - gene therapy additionally, he explored the intersection between neuro-ontogenesis and neuro-oncogenesis, identifying afp and igf-i as novel biomarkers, which have implications for understanding central nervous system differentiation and cancer progression.

Accolades and recognition 🏆

In recognition of his substantial contributions to biomedical science, jerzy was elected as a member of the prestigious french academy of medicine (anm) in paris in 2017. his extensive body of work includes nearly 370 publications, encompassing 140 articles, 102 book chapters, and four books, which have garnered over 3,500 Immuno - gene therapy citations. this impressive scholarly output underscores his impact and influence in the field of cancer research.

Impact and influence 🌍

Dr. trojan's research has significantly shaped the landscape of cancer therapy, particularly in immunotherapy. his establishment of immuno-gene therapy has opened new avenues for treating aggressive cancers, thus influencing both academic research and clinical practices. his work has not only contributed to theoretical Immuno - gene therapy advancements but has also informed practical applications that benefit patients facing challenging diagnoses.

Legacy and future contributions 🔮

With an enduring commitment to advancing cancer research, jerzy trojan continues to influence the field through his current role as a visiting professor and research director. his legacy is evident in the ongoing projects aimed at improving cancer treatment outcomes, particularly through innovative therapeutic strategies. as he continues to publish and mentor the next generation of researchers, his contributions will undoubtedly have a lasting impact on the future of oncology and gene therapy.

Notable Publications

Title: Precancerous Disease Systemic Lupus Erythematosus–The Role of BAFF in Corticosteroids Treatment
Author: J. Trojan et al.
Journal: Medical Research and Its Applications, Vol. 6, Pages 114-127
DOI: 10.9734/bpi/mria/v6/7520C
Publication Date: June 3, 2024
Title: Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
Author: J. Trojan
Journal: Current Medicinal Chemistry, Vol. 31, Pages 1982-2002
DOI: 10.2174/0109298673231106095141
Publication Date: March 11, 2024
Title: Establishment of Cancer Gene Therapy
Author: J. Trojan
Journal: Cambridge Scholars Publishing
Publication Date: March 2, 2023
Title: Neoplastic brain, glioblastoma and immunotherapy
Author: J. Trojan et al.
Journal: In: Brain and Spinal Tumors - Primary and Secondary, Ed. L.R. Morgan, F.B. Sarica, InTechOpen
Publication Date: 2020
Title: In vitro technical aspects of Anti–Gene IGF-I vaccines against glioma
Author: J. Trojan et al.
Journal: IBR, Vol. 3(1), Pages 43-48
Publication Date: 2019

Dr. Subash Chandra Sonkar – Medical Science – Best Researcher Award

Posted on 04/11/202404/11/2024 by sciencefatherLeave a Comment

Dr. Subash Chandra Sonkar - Medical Science - Best Researcher Award

Maulana Azad Medical College and Associated Hospitals New Delhi, India - India

Author Profile

SCOPUS

ORCID

🌱 Early academic pursuits

Dr. Subash Chandra Sonkar's academic journey began with a b.sc. in chemistry, botany, and zoology from v.b.s. purvanchal university, jounpur, uttar pradesh. his passion for science deepened as he pursued an m.sc. in applied microbiology at banaras hindu university, where he conducted research under the mentorship of prof. arti kapil at aiims, new delhi. dr. sonkar's academic career culminated with a ph.d. in biomedical science from the university of delhi, under the guidance of prof. daman saluja, focusing on designing naat-based diagnostic assays for trichomonas vaginalis detection.

🔬 Professional endeavors

Dr. Sonkar's professional journey has been marked by a series of impactful roles. he has served as a research scientist-ii at the multidisciplinary research unit of maulana azad medical college, contributing to important medical research projects. his experience extends to advisory positions, including his role as a technical advisor for the indian council of medical research (icmr), where he contributed to national mental health capacity building programs.

💡 Contributions and research focus

Dr. Sonkar’s contributions to public health and biomedical science are vast, particularly in the areas of diagnostics and viral infections. he has led research on the role of viral infections in adverse birth outcomes and the development of point-of-care diagnostic devices, including rt-lamp and lfa-based assays for sars-cov-2. his Medical Science postdoctoral research also includes designing multiplex diagnostic kits for detecting sexually transmitted infections.

🏆 Accolades and recognition

Throughout his career, dr. sonkar has garnered recognition for his pioneering research and innovation. he has been a postdoctoral fellow at prestigious institutions like the public health research institute of india and vardhmaan mahaveer medical college. his work in diagnostic assays and medical devices has earned him Medical Science international acclaim, particularly in public health and biomedical sciences.

🌍 Impact and influence

Dr. Sonkar’s research has had a far-reaching impact on public health, particularly in india. his work on diagnostics for viral infections and sexually transmitted diseases has improved early detection and contributed to better healthcare outcomes. his role in the development of diagnostic kits during the covid-19 pandemic Medical Science highlights his significant contributions to global health.

🔗 Legacy and future contributions

Dr. Sonkar’s legacy lies in his multidisciplinary approach to biomedical research. his expertise in diagnostics, public health, and medical device development positions him as a leader in healthcare innovation. his future contributions are expected to further advance diagnostics and public health, ensuring better healthcare access and outcomes worldwide.

Notable Publications

Title: Insights into the Emergence and Evolution of Monkeypox Virus: Historical Perspectives, Epidemiology, Genetic Diversity, Transmission, and Preventative Measures
Authors: Krishna, S., Kurrey, C., Yadav, M., Chandra, L., Koner, B.C.
Journal: Infectious Medicine, 2024, 3(2), 100105
Title: Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Authors: Sakthivel, S., Srivastava, M., Barman, M.K., Sonkar, S.C., Bhukya, P.
Journal: Research Anthology on Bioinformatics, Genomics, and Computational Biology, 2024, pp. 428–456
Title: Molecular Farming and Anticancer Vaccine: Current Opportunities and Openings
Authors: Ratre, Y.K., Mehta, A., Shinde, S., Shukla, D., Vishvakarma, N.K.
Journal: Microbial Bioreactors for Industrial Molecules, 2023, pp. 355–373
Title: Preface
Authors: Bhukya, P.L., Mhaske, S.T., Sonkar, S.C.
Journal: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever, 2023, 1, pp. ix
Title: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever
Authors: Bhukya, P.L., Mhaske, S.T., Sonkar, S.C.
Journal: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever, 2023, 1, pp. 1–587

Dr. Camila De Oliveira Melo – Nanotecnologia – Young Scientist Award

Posted on 09/10/202409/10/2024 by sciencefatherLeave a Comment

Dr. Camila De Oliveira Melo - Nanotecnologia - Young Scientist Award

Universidade Estadual da Paraíba - Brazil

Author Profile

SCOPUS

ORCID

🎓 Early academic pursuits

Camila De Oliveira melo began her journey into the world of pharmaceuticals with a bachelor’s degree in pharmacy from universidade estadual da paraíba (uepb) in 2015. her early academic interests focused on innovative drug delivery systems, specifically the pre-formulation study of polymeric nanoparticles to carry l-asparaginase, a promising approach for cancer treatment. her drive to explore advanced biotechnological solutions led her to pursue a master’s degree in pharmaceutical sciences (2018), where she worked on pla nanoparticles containing spiro-acridinic derivatives with anticancer activity. her strong foundation in biotechnology and pharmacy culminated in her doctoral degree from rede nordeste de biotecnologia (renorbio) at universidade federal do rio grande do norte (ufrn), where she focused on drug delivery systems aimed at cancer therapy using spiro-acridinic derivatives.

🔬 Professional endeavors

Camila’s professional experience is deeply rooted in biotechnology and pharmaceutical sciences. she has worked extensively in developing polymeric nanoparticles, contributing to innovative cancer treatments. her research during her doctorate involved the development and biological evaluation of spiro-acridinic-derived drug delivery systems, demonstrating her commitment to advancing cancer therapies. her expertise also extends to the creation of nanoemulsions containing essential oils, which offer potential in various pharmaceutical applications. camila has shown consistent dedication to improving the efficacy and solubility of hydrophobic drugs through inclusion complexes, broadening her contribution to pharmaceutical sciences.

🧬 Contributions and research focus

Camila's primary research focus lies in the development of cutting-edge drug delivery systems. her work has emphasized the creation of polymeric nanoparticles, specifically pla-based systems, aimed at improving the accumulation of therapeutic agents in tumor tissues via the enhanced permeability and retention (epr) effect. Nanotecnologia her research has contributed significantly to the advancement of cancer treatment, with a focus on increasing the bioavailability and effectiveness of hydrophobic drugs. additionally, camila’s exploration of nanoemulsions and inclusion complexes has opened doors for future applications in drug solubility and targeted delivery.

🏆 Accolades and recognition

in 2022, camila was recognized as one of the six brazilian researchers selected for the prestigious course "nanobiotecnologia aplicada ao combate da covid19," funded by the ministry of science, technology, and innovations (mctic). this recognition highlights her role as a leading figure in nanotechnology applications in brazil, Nanotecnologia particularly her expertise in employing nanoparticles for critical health challenges like cancer and covid-19. her work has been supported by notable funding bodies like the foundation for research support of the state of paraíba (fapesq), showcasing the trust in her research contributions.

🌍 Impact and influence

Camila’s contributions to cancer research, particularly in the area of nanoparticle-based drug delivery systems, have had a significant impact on the field of pharmaceutical biotechnology. her research has the potential to revolutionize cancer treatment by offering more effective drug delivery methods, enhancing drug Nanotecnologia solubility, and reducing side effects. her work on nanoemulsions and inclusion complexes also presents a wide range of pharmaceutical applications, influencing future research in drug development. camila's selection for the nanobiotechnology course reflects her growing influence in both national and international scientific communities.

🔮 Legacy and future contributions

Camila de Oliveira melo’s legacy lies in her groundbreaking research on nanoparticle-based drug delivery systems for cancer therapy. her work is a testament to her commitment to innovation and improving patient outcomes. moving forward, she is likely to continue making strides in the development of advanced drug delivery technologies, with the potential to influence future research in oncology, nanotechnology, and biopharmaceuticals. her expertise in enhancing drug solubility and efficacy positions her as a key player in the future of pharmaceutical biotechnology.

Notable Publications

Title: Enhancing the Antischistosomal Activity of Carvacryl Acetate Using Nanoemulsion
Authors: De Souza, R.L., Mengarda, A.C., Roquini, D.B., Moraes, J.D., Oliveira, E.E.
Journal: Nanomedicine, 2023, 18(4), pp. 331–342
Title: Nanotechnology as a Tool to Improve the Biological Activity of Carvacrol: A Review
Authors: Souza, R.L.D., Dantas, A.G.B., Melo, C.D.O., Felício, I.M., Oliveira, E.E.
Journal: Journal of Drug Delivery Science and Technology, 2022, 76, 103834
Title: Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis
Authors: Xavier, E.S., de Souza, R.L., Rodrigues, V.C., Oliveira, E.E., de Moraes, J.
Journal: Frontiers in Pharmacology, 2022, 13, 917363
Title: The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases
Authors: Da Silva, P.R., Do Espírito Santo, R.F., Melo, C.O., de Moura, R.O., Dos Santos, V.L.
Journal: Pharmaceutics, 2022, 14(1), 188
Title: Xylan Microparticles for Controlled Release of Mesalamine: Production and Physicochemical Characterization
Authors: Urtiga, S.C.D.C., Alves, V.M.O., Melo, C.D.O., Oliveira, E.E., Egito, E.S.T.D.
Journal: Carbohydrate Polymers, 2020, 250, 116929

Dr. Awanish Kumar – Drug Discovery and development – Excellence in Research

Posted on 08/10/202408/10/2024 by sciencefatherLeave a Comment

Dr. Awanish Kumar - Drug Discovery and development - Excellence in Research

NIT Raipur - India

Author Profile

SCOPUS

ORCID

🌱 Early academic pursuits

Dr. Awanish Kumar's journey into biotechnology began with an m.sc. in biotechnology from devi ahilya university, indore, where he graduated with first division honors, securing an impressive 75.9%. his thirst for knowledge and passion for research led him to pursue a ph.d. at the prestigious jawaharlal nehru university (jnu), new delhi, and the central drug research institute (cdri), lucknow. during this time, he delved deeply into biotechnology, laying a strong foundation for his future research in antifungal therapeutics and microbial biology.

👨‍🏫 Professional endeavors

currently, Dr. Awanish kumar serves as an associate professor at the department of biotechnology, national institute of technology (nit), raipur. since april 2022, he has been mentoring students, guiding cutting-edge research, and contributing to the growth of the department. his academic career also includes a post-doctoral fellowship at jnu, where he worked on a ugc-funded project investigating the antifungal properties of curcumin, a bioactive compound from curcuma longa.

🔬 Contributions and research focus

Dr. Kumar’s research is centered around antimicrobial peptides, drug delivery systems, and antifungal therapeutics. under his mentorship, two ph.d. students Drug Discovery and development completed their research on topics like the isolation of antifungal peptides from microbes and the design of biopolymeric microneedle patches for transdermal drug delivery. his ongoing projects include studies on biofilm disruption, redox nanomaterials, and the evaluation of natural compounds for their antifungal properties. one of his notable research contributions is demonstrating how curcumin induces apoptosis in candida albicans by generating reactive oxygen species and activating caspase-3.

🏆 Accolades and recognition

dr. Kumar’s achievements in research have not gone unnoticed. he was awarded the prestigious ugc ds kothari fellowship, recognizing him as an emerging young Drug Discovery and development investigator. this fellowship provided him the opportunity to lead significant research on antifungal mechanisms, especially curcumin’s role in modulating efflux activities in candida albicans. his innovative work on biopolymers and antifungal biomaterials has earned him acclaim in academic circles.

🌍 Impact and influence

Dr. Kumar’s work in biotechnology, particularly his studies on antifungal peptides and curcumin’s therapeutic potential, has significant implications in both medicine and agriculture. his pioneering efforts in designing biopolymeric patches for drug delivery and developing antifungal biomaterials are set to influence future research in fungal pathogen treatment. he continues to inspire the next generation of researchers through his mentorship and collaborative projects in microbial biotechnology.

💡 Legacy and future contributions

Dr. Kumar's contributions to antifungal research and biopharmaceutical sciences are building a legacy in microbial biotechnology. with three ongoing ph.d. projects under his guidance and several groundbreaking discoveries already under his belt, he is shaping the future of antifungal therapeutics. his focus on developing Drug Discovery and development commercial applications for antifungal biomaterials highlights his forward-thinking approach and commitment to bringing research from the lab to real-world applications.

Notable Publications

Title: Acetaminophen induces mitochondrial apoptosis through proteasome dysfunctions
Authors: Jagtap, Y.A., Kumar, P., Dubey, A.R., Prasad, A., Mishra, A.
Journal: Life Sciences, 2024, 349, 122732
Title: Nanomaterials-Based Hybrid Bioink Platforms in Advancing 3D Bioprinting Technologies for Regenerative Medicine
Authors: Chandra, D.K., Reis, R.L., Kundu, S.C., Kumar, A., Mahapatra, C.
Journal: ACS Biomaterials Science and Engineering, 2024, 10(7), pp. 4145–4174
Title: Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries
Authors: Dönmez, A.E., Goswami, A.G., Raheja, A., Osama, Z., Dauksa, Z.
Journal: The Lancet Global Health, 2024, 12(7), pp. e1094–e1103
Title: Development of the dynamic approach for detection of Salmonella Typhi biofilm via optimizations of interaction with safranin dye
Authors: Upadhyay, A., Pal, D., Kumar, A.
Journal: Biologia, 2024, 79(7), pp. 2299–2309
Title: Application of Invasive Weed Biochar as Soil Amendment Improves Soil Organic Carbon Fractions and Yield of Fodder Oat in a Semi-Arid Region
Authors: Prasad, M., Choudhary, P., Choudhary, M., Palsaniya, D.R., Kumar, S.
Journal: Journal of Soil Science and Plant Nutrition, 2024, 24(2), pp. 2111–2122

Dr. Vikas Shukla – Nanomedicine and Immunology – Best Researcher Award

Posted on 25/09/202425/09/2024 by sciencefatherLeave a Comment

Dr. Vikas Shukla - Nanomedicine and Immunology - Best Researcher Award

AIIMS, New Delhi - India

Author Profile

GOOGLE SCHOLAR

Early academic pursuits 📚

Vikas Shukla's academic journey began with a deep-rooted passion for nanobiotechnology and immunology. He dedicated himself to gaining a solid foundation in the life sciences, eventually leading him to pursue advanced studies in these cutting-edge fields. His education, characterized by rigorous training, provided the tools necessary for his future contributions to scientific research. Over the years, vikas built an impressive knowledge base in bacterial culture, cell culture, and immunoassays, which would serve as the backbone of his research career.

Professional endeavors 🏢

currently serving as a research scientist-II at the all india institute of medical sciences (aiims) in new delhi, india, vikas brings over 8 years of extensive experience to the forefront. His role at aiims, within the department of plastic, reconstructive & burns surgery, involves not only laboratory-based research but also project management. This balance between hands-on science and overseeing project timelines ensures that he contributes effectively to the scientific and clinical goals of his department.

Contributions and research focus 🔬

Vikas's research primarily revolves around nanobiotechnology and immunology, with a keen focus on innovative solutions in medical science. He has demonstrated exceptional expertise in bacterial culture, cell culture, immunoassays, and small animal handling. His work seeks to bridge the gap between complex scientific Nanomedicine and Immunology theories and their real-world applications, particularly in healthcare. Vikas’s research outputs have helped advance understanding in both fundamental immunological responses and the application of nanotechnology in therapeutic treatments.

Accolades and recognition 🏅

throughout his career, vikas has received commendations for his meticulous work and contributions to the field. His ability to keep projects both on time and on Nanomedicine and Immunology budget while maintaining high scientific standards has not gone unnoticed. He is widely recognized among his peers and colleagues for his diligence, precision, and ability to translate complex scientific concepts into more accessible knowledge. His exceptional communication skills have further bolstered his reputation as a skilled researcher and project manager.

Impact and influence 🌍

Vikas’s research holds significant implications for the fields of immunology and nanobiotechnology, particularly within clinical settings. His work on developing innovative medical treatments and enhancing immunological responses has the potential to save lives and improve patient outcomes. His influence extends beyond the laboratory, as his project management skills ensure that critical research is completed efficiently, benefiting both the scientific community and society as a whole.

Legacy and future contributions 🔮

looking ahead, Vikas Shukla’s legacy will likely be defined by his contributions to advancing the use of nanotechnology in medicine. His ongoing work at aiims and within the broader scientific community will continue to impact the development of new therapeutic approaches and enhance our understanding of immune Nanomedicine and Immunology responses. His commitment to pushing the boundaries of science while managing complex projects ensures that his influence will be felt for years to come.

Notable Publications

Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives 2021

Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology 2023

Downmodulation of lysophosphatidic acid by Berberine loaded folate-conjugated glycol chitosan nanoparticles 2022

Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects 2022

Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment 2024

Dr. Hina Khalid – Biotechnology – Best Researcher Award

Posted on 24/06/202424/06/2024 by sciencefatherLeave a Comment

Dr. Hina Khalid - Biotechnology - Best Researcher Award

Shandong University of Technology - China

Professional Profile

SCOPUS

ORCID

Early Academic Pursuits

Dr. Hina Khalid began her academic journey with a Bachelor of Science (BS) Honours in Bioinformatics from Government College University, Faisalabad, followed by a Master of Science (MS) in Biotechnology. She completed her Ph.D. in Biotechnology from the same institution in 2021, focusing on innovative approaches in molecular biology and immunoinformatics.

Professional Endeavors

Dr. Khalid's research career has been marked by significant contributions across various institutions. She served as a Research Associate at Government College University, Faisalabad, where she led projects investigating the therapeutic potential of synthetic compounds against Biotechnology Hepatitis C Virus (HCV). Her work integrated insilico approaches with experimental validations, employing molecular docking, Real-Time PCR, and western blotting techniques.

Contributions and Research Focus

Dr. Khalid's research interests span a wide array of disciplines within biotechnology and molecular biology. She has expertise in cell biology, microscopy/imaging, immunology, biochemistry, genomics, and bioinformatics. Her notable contributions include the development of novel Biotechnology therapies for HCV, insights into cancer stem cells in hepatocellular cancer, and the design of multi-epitope vaccines against viral infections using immunoinformatics approaches.

Accolades and Recognition

Dr. Khalid's research has been widely recognized through numerous publications in high-impact journals and several awards. She has authored papers on topics ranging from viral infections to cancer biology, showcasing her expertise in elucidating complex biological mechanisms and Biotechnology developing therapeutic interventions.

Impact and Influence

Dr. Khalid's work has had a profound impact on the fields of biotechnology and immunoinformatics, particularly in advancing the understanding of viral diseases and cancer biology. Her contributions in designing novel therapeutic strategies and vaccines reflect her commitment to Biotechnology addressing global health challenges through innovative research.

Legacy and Future Contributions

Dr. Khalid's legacy is characterized by her pioneering research in immunoinformatics and molecular biology, aimed at developing targeted therapies and vaccines. Her future contributions are poised to continue pushing the boundaries of biotechnological research, with a focus on enhancing disease prevention and treatment strategies. As she progresses in her career, Dr. Khalid remains dedicated to leveraging her Biotechnology expertise to make transformative advancements in healthcare and biotechnology.

NOTABLE PUBLICATIONS

Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant 2024

In-silico elucidation reveals potential phytochemicals against angiotensin-converting enzyme 2 (ACE-2) 2022(1)

Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase 2022 (2)

Discovery of Novel HCV NS5B polymerase inhibitor, 2-(3,4-dimethyl-5,5-dioxidobenzo[e]pyrazolo[4,3-c][1,2] 2021(5)

Phytochemical analysis and antidiabetic potential of armoracia rusticana: Pharmacological and computational approach 2021(6)

Dr. Vikrant Khare – Genetics and Plant Breeding – Excellence in Research

Posted on 24/06/202424/06/2024 by sciencefatherLeave a Comment

Dr. Vikrant Khare - Genetics and Plant Breeding - Excellence in Research

Bhabha Atomic Research Centre, GOI, Mumbai - India

Professional Profile

SCOPUS

ORCID

Early Academic Pursuits

Dr. Vikrant Khare's academic foundation was built in Madhya Pradesh, India. He completed his high school education in 2004 with a focus on mathematics, science, social science, and languages. His higher secondary education, completed in 2006, focused on physics, chemistry, biology, and languages. Dr. Khare then pursued a Bachelor of Science in Agriculture from Assam Agriculture University, graduating in 2014. His academic journey continued with a Master's degree in Genetics and Plant Breeding from Punjab Agriculture University, completed in 2017. Dr. Khare achieved his Ph.D. in Genetics and Plant Breeding from Jawaharlal Nehru Agriculture University in 2022.

Professional Endeavors

Dr. Khare has accumulated over three years of research experience in various esteemed institutions. He is currently a Research Associate at the Bhabha Atomic Research Centre in Mumbai, Maharashtra, working on a Department of Atomic Energy-funded network project. Prior to this, he served as a Junior Research Fellow in a DBT project at Jawaharlal Nehru Agriculture University and worked as an Agriculture Scientist in the Agrolok Project at Lok Bharati Wheat Research Centre in Gujarat.

Contributions and Research Focus

Dr. Khare's research focuses on the genetic and molecular analysis of crops, aiming to improve agricultural practices through advanced breeding and biotechnological tools. His Master's thesis explored the morphological and molecular marker analysis of rye chromosome introgressions in wheat. His Ph.D. thesis investigated genetic studies and molecular validation of wheat recombinant inbred lines (RILs) under heat and moisture Genetics and Plant Breeding stress conditions. His technical expertise includes genomic DNA isolation, RT PCR, DNA barcoding, population mapping, QTL analysis, marker-assisted backcrossing, and bioinformatics.

Accolades and Recognition

Dr. Khare's contributions to the field of genetics and plant breeding have been recognized with several prestigious awards. He received the ICAR Junior/Senior Research Fellowship for his Ph.D. program and the ICAR National Talent Search Scholarship for both his B.Sc. and M.Sc. degrees. In 2023, he was honored with the Outstanding Researcher Award at the International Conference on One Health - One World, the Young Scientist Award at the International Conference on Natural & Organic Farming, and the Eminent Scientist Award at the International Conference on Impact of Climate Changes on Global Food, Livestock, Livelihood, and Genetics and Plant Breeding Environmental Security.

Impact and Influence

Dr. Khare's research has significantly impacted the field of sustainable agriculture, particularly through his work on genetic and genomic resources for crop improvement. His efforts in molecular biology and plant breeding have contributed to the development of advanced Genetics and Plant Breeding agricultural practices and technologies, aiming to enhance crop resilience and productivity under environmental stress conditions.

Legacy and Future Contributions

Dr. Khare's legacy is marked by his dedication to advancing agricultural science through innovative research and practical applications. His work on genetic studies and molecular validation in crops has set a foundation for future research aimed at improving agricultural sustainability and food security. As he continues his research at the Bhabha Atomic Research Centre, Dr. Khare is poised to make further significant contributions to the field, driving advancements in sustainable agriculture and crop improvement technologies.

NOTABLE PUBLICATIONS

Exploring the genotype-environment interaction of bread wheat in ambient and high-temperature 2024(1)

Holistic approach to ascertain genetic variability and responsive trait selection for different heat regimes 2024

Comprehensive analysis of phenotypic variation and selection strategies for yield-related traits in recombinant 2023

Multivariate analysis and role of direct–indirect effect for yield and its component traits in bread wheat (Triticum aestivum L.) 2022(3)